Literature DB >> 28557753

Oral Corticosteroid Prescribing for Children With Asthma in a Medicaid Managed Care Program.

Harold J Farber1,2,3, Edwin A Silveira4, Douglas R Vicere4, Viral D Kothari2, Angelo P Giardino2.   

Abstract

BACKGROUND AND
OBJECTIVE: Short courses of oral corticosteroid (OCS) medication are recommended for treatment of moderate to severe asthma exacerbations. Concern has been raised about OCS overuse. Our objective is to describe rates of OCS dispensing among children with asthma and factors associated with variation in OCS dispensing.
METHODS: Claims data for children 1 to <18 years of age with an asthma diagnosis between January 2011 and January 2016 were extracted from the computerized databases of Texas Children's Health Plan.
RESULTS: In the years 2011 to 2015, 17.1% to 21.8% of children had an asthma diagnosis. In each of these years 42.1% to 44.2% of these children had ≥1 OCS dispensing. OCS dispensing rates were higher for the children 1 to 4 years of age compared with older children. Repeated OCS dispensing was common, and was most common for children 1 to 4 years of age. Most children with an OCS dispensing (81%-83%) did not have other utilization suggesting poor asthma control (excessive β-agonist refills, emergency department visit, or hospitalization for asthma). OCSs were less commonly prescribed to patients whose primary care provider was a board-certified pediatrician compared with other types of primary care providers. There was large variation in OCS prescribing rates among pediatricians (15%-86%). There were minimal differences in asthma emergency department visits and no differences in hospitalization rates by the pediatrician's OCS dispensing rate quartile.
CONCLUSIONS: The patterns of dispensing observed suggest substantial overprescribing of OCS for children with an asthma diagnosis.
Copyright © 2017 by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28557753     DOI: 10.1542/peds.2016-4146

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Things We Do for No Reason: Systemic Corticosteroids for Wheezing in Preschool-Aged Children.

Authors:  Yemisi O Jones; Brittany B Hubbell; Joanna Thomson; Jennifer K O'Toole
Journal:  J Hosp Med       Date:  2019-07-24       Impact factor: 2.960

2.  Development and initial validation of the Asthma Severity Scoring System (ASSESS).

Authors:  Anne M Fitzpatrick; Stanley J Szefler; David T Mauger; Brenda R Phillips; Loren C Denlinger; Wendy C Moore; Ronald L Sorkness; Sally E Wenzel; Peter J Gergen; Eugene R Bleecker; Mario Castro; Serpil C Erzurum; John V Fahy; Benjamin M Gaston; Elliot Israel; Bruce D Levy; Deborah A Meyers; W Gerald Teague; Leonard B Bacharier; Ngoc P Ly; Wanda Phipatanakul; Kristie R Ross; Joe Zein; Nizar N Jarjour
Journal:  J Allergy Clin Immunol       Date:  2019-10-08       Impact factor: 10.793

3.  Comparison of severity of asthma hospitalization between African American and Hispanic children in the Bronx.

Authors:  Diana S Lee; Elissa Gross; Arda Hotz; Deepa Rastogi
Journal:  J Asthma       Date:  2019-05-07       Impact factor: 2.515

4.  Tiotropium as an Add-on Treatment Option for Severe Uncontrolled Asthma in Preschool Patients.

Authors:  Stefan Zielen; Gianna Reichert; Helena Donath; Jordis Trischler; Johannes Schulze; Olaf Eickmeier; Martin Eckrich; Katharina Blumchen
Journal:  J Asthma Allergy       Date:  2021-01-14

5.  Pediatric Asthma Exacerbation in Children with Suspected and Confirmed Coronavirus Disease 2019 (COVID-19): An Observational Study from Saudi Arabia.

Authors:  Ali Alsuheel Asseri
Journal:  J Asthma Allergy       Date:  2021-09-23

6.  Pediatric Outpatient Prescriptions in Countries With Advanced Economies in the 21st Century: A Systematic Review.

Authors:  Marion Taine; Lucile Offredo; Alain Weill; Rosemary Dray-Spira; Mahmoud Zureik; Martin Chalumeau
Journal:  JAMA Netw Open       Date:  2022-04-01

7.  The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial.

Authors:  Madeleine Rooney; Nick Bishop; Joyce Davidson; Michael W Beresford; Clarissa Pilkington; Janet Mc Donagh; Sue Wyatt; Janet Gardner-Medwin; Rangaraj Satyapal; Jacqui Clinch; Helen Foster; Mark Elliott; Rejina Verghis
Journal:  EClinicalMedicine       Date:  2019-07-03

8.  Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management.

Authors:  Eugene R Bleecker; Andrew N Menzies-Gow; David B Price; Arnaud Bourdin; Stephen Sweet; Amber L Martin; Marianna Alacqua; Trung N Tran
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

9.  Complications and Health Care Resource Utilization Associated with Systemic Corticosteroids in Children and Adolescents with Persistent Asthma.

Authors:  Patrick W Sullivan; Vahram H Ghushchyan; David P Skoner; Jason LeCocq; Siyeon Park; Robert S Zeiger
Journal:  J Allergy Clin Immunol Pract       Date:  2020-12-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.